B2 Flashcards

(17 cards)

1
Q

What is a null infection in the context of viral infection in vitro?

A

A null infection occurs when a virus cannot attach to or penetrate the cell, resulting in no infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is an abortive infection?

A

An abortive infection occurs when a virus can enter the cell but cannot produce infectious progeny, often because the cell is non-permissive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is a cytopathic effect in viral infection?

A

A cytopathic effect refers to cell damage or death caused by viral infection through mechanisms such as lysis or apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does cell fusion occur during a viral infection?

A

During a viral infection, cell fusion can occur, leading to the formation of a syncytium, a multi-nucleated cell formed by the fusion of infected cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a persistent infection in vitro?

A

A persistent infection occurs when the virus replicates and continuously releases progeny while the cell or cell population survives.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define latent infection in the context of viral infection.

A

In a latent infection, the viral genome remains in the cell without producing progeny until it is reactivated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does transformation mean in viral infection?

A

Transformation refers to the process by which viral infection results in the immortalisation of a cell line, indicating that the cell is permissive.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the primary components of the innate immune response to viral infection?

A

The innate response includes natural killer cells and interferons (IFNα, IFNβ, IFNγ).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do NK cells recognise infected cells?

A

NK cells recognise infected cells by detecting alterations or absence of MHC class I molecules, triggering the release of cytotoxic granules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the role of interferons in viral infection?

A

Interferons inhibit viral replication, activate immune cells, enhance antigen presentation, and induce an antiviral state in target cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Name the three major antiviral effector molecules (AVEM) in interferon response.

A

PKR (dsRNA-dependent protein kinase), OAS (oligo A synthetase), and RNAse L.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is antibody-dependent cellular cytotoxicity (ADCC)?

A

ADCC is the destruction of virus-infected cells by immune cells (e.g., NK cells, macrophages) that recognise antibodies bound to viral antigens on infected cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the three primary antibody isotypes involved in antiviral responses?

A

IgM (early infection indicator), IgA (mucosal immunity), and IgG (systemic immunity and placental transfer).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

: What is antigenic drift?

A

Antigenic drift involves small mutations in viral surface proteins, such as hemagglutinin, allowing the virus to evade neutralising antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is antigenic shift?

A

Antigenic shift occurs when RNA segments are exchanged between different viral strains, creating a novel virus against which the host has little to no immunity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can viruses evade immune responses passively?

A

Passive evasion includes antigenic variation, compartmentalisation (e.g., neurons for HSV), and latency without antigen production.

17
Q

How do some viruses actively evade immune responses?

A

Active evasion involves interfering with IFN signalling (e.g., HCV) or blocking MHC antigen presentation (e.g., HSV).